Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aelios Finance was a prominent French investment bank and corporate finance advisory firm that specialized in the small and mid-cap segments. Established in 2004, the firm provided a range of services including mergers and acquisitions (M&A) advisory, private placements, and fundraising, with a strong sector focus on healthcare, life sciences, and technology. In 2016, Aelios Finance merged with the global M&A firm Oaklins to become Oaklins France, significantly expanding its international reach and cross-border transaction capabilities. The firm was a key player in the French financial landscape, frequently advising biotech and medtech companies on strategic growth and exit strategies. Its legacy continues through Oaklins France, which maintains a dedicated healthcare practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aelios Finance.